Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19⁺ B cell tumors: a phase 1/2 trial

David Marin, Ye Li, Rafet Basar, Hind Rafei, May Daher, Jinzhuang Dou, Vakul Mohanty, Merve Dede, Yago Nieto, Nadima Uprety, Sunil Acharya, Enli Liu, Jeffrey Wilson, Pinaki Banerjee, Homer A. Macapinlac, Christina Ganesh, Peter F. Thall, Roland Bassett, Mariam Ammari, Sheetal RaoKai Cao, Mayra Shanley, Mecit Kaplan, Chitra Hosing, Partow Kebriaei, Loretta J. Nastoupil, Christopher R. Flowers, Sadie Mae Moseley, Paul Lin, Sonny Ang, Uday R. Popat, Muzaffar H. Qazilbash, Richard E. Champlin, Ken Chen, Elizabeth J. Shpall, Katayoun RezvaniShow 16 othersShow less